Financhill
Back

Verizon Communications, Inc. Vs. Spyre Therapeutics, Inc. Industry Stock Comparison

Sell
47

VZ
Verizon Communications, Inc.

Last Price:
$49.28
Seasonality Move:
-1.04%
Buy
72

SYRE
Spyre Therapeutics, Inc.

Last Price:
$43.26
Seasonality Move:
-1.59%
Sell
47
Verizon Communications, Inc. (VZ) is a Sell

Is Verizon Communications, Inc. a Buy, Sell or Hold?

  • The current Verizon Communications, Inc. [VZ] share price is $49.25. The Score for VZ is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • VZ is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
72
Spyre Therapeutics, Inc. (SYRE) is a Buy

Is Spyre Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Spyre Therapeutics, Inc. [SYRE] share price is $43.21. The Score for SYRE is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
  • SYRE is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

VZ Stock Price Chart

What is Verizon Communications, Inc.'s stock price today?

  • The Verizon Communications, Inc. share price today is $49.25
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VZ is experiencing buying pressure, which is a positive indicator for future bullish movement.

SYRE Stock Price Chart

What is Spyre Therapeutics, Inc.'s stock price today?

  • The Spyre Therapeutics, Inc. share price today is $43.21
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SYRE is experiencing buying pressure, which is a positive indicator for future bullish movement.

VZ Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.17 Buy
Relative Strength Index (14 RSI): 74.48 Buy
Chaikin Money Flow: 20113959 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (40.09 - 48.41) Buy
Bollinger Bands (100): (38.73 - 44.27) Buy

SYRE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 7.48 Buy
Relative Strength Index (14 RSI): 76.95 Buy
Chaikin Money Flow: 2001107 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (31.94 - 36.64) Buy
Bollinger Bands (100): (22.31 - 34.55) Buy

VZ Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 48.71 Buy
20-day SMA: 45.51 Buy
50-day SMA: 42.27 Buy
200-day SMA: 42.38 Buy
8-day EMA: 25.81 Buy
20-day EMA: 12.63 Buy
50-day EMA: 5.5 Buy
200-day EMA: 1.44 Buy

SYRE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.57 Buy
20-day SMA: 34.45 Buy
50-day SMA: 33.41 Buy
200-day SMA: 22.2 Buy
8-day EMA: 21.06 Buy
20-day EMA: 10.23 Buy
50-day EMA: 4.44 Buy
200-day EMA: 1.16 Buy

Verizon Communications, Inc. Earnings Growth & VZ Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.23 per share, and an increase next year of $0.34 per share.

Spyre Therapeutics, Inc. Earnings Growth & SYRE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.46 per share, a decrease this year of $0.85 per share, and an increase next year of $0.08 per share.

Verizon Communications, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Spyre Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):